NASDAQ:GOSS | Free Cash Flow | Gossamer Bio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$38.72M$0.00-$38.72M
2025-12-31-$48.31M$0.00-$48.31M
2025-03-31-$39.72M$26,000.00-$39.75M
2024-12-31-$35.48M$0.00-$35.48M
2024-03-31-$52.3M$0.00-$52.3M
2023-12-31-$33.42M$0.00-$33.42M
2023-03-31-$52.99M$0.00-$52.99M
2022-12-31-$47.73M$102,000.00-$47.83M
2022-03-31-$53.48M$157,000.00-$53.64M
2021-12-31-$40.51M$83,000.00-$40.59M
2021-03-31-$58.9M$802,000.00-$59.7M
2020-12-31-$36.74M$250,000.00-$36.99M
2020-03-31-$52.3M$513,000.00-$52.81M
2019-12-31-$44.14M$528,000.00-$44.67M
2019-03-31-$27.77M$347,000.00-$28.12M
2018-12-31-$25.02M$322,000.00-$25.35M
2018-03-31-$3.71M$511,000.00-$4.22M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$171.27M$79,000.00-$171.35M
2024-12-31-$3.47M$0.00-$3.47M
2023-12-31-$159.16M$0.00-$159.16M
2022-12-31-$187.03M$410,000.00-$187.44M
2021-12-31-$188.89M$1.55M-$190.44M
2020-12-31-$176.36M$1.5M-$177.86M
2019-12-31-$144.83M$2.97M-$147.8M
2018-12-31-$51.04M$3.49M-$54.53M
2017-12-31-$5.75M